Literature DB >> 12149222

Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation.

Jessica H Roark1, James B Bussel, Douglas B Cines, Don L Siegel.   

Abstract

Although idiopathic thrombocytopenic purpura (ITP) is the most common autoimmune hematologic disorder, little is known about the associated autoantibodies on a molecular level. Consequently, diagnostic assays and therapy for ITP lack specificity. To avoid technical limitations imposed by B-cell immortalization methods, we used repertoire cloning (Fab/phage display) to clone platelet autoantibodies and examine the relation between immunoglobulin (Ig) gene usage, clonality, and antigen specificity. Phage display libraries were constructed from splenocytes from 2 patients with chronic ITP, and competitive cell-surface selection was used to isolate several dozen unique IgG platelet-specific autoantibodies. Platelet-reactive Fabs in both patients were associated almost exclusively with rearrangements of a single Ig heavy-chain variable-region gene (V(H)3-30), despite an apparent diversity of antigen specificities. Comparative analysis of platelet-reactive Fab Ig gene rearrangements from each patient suggested that they evolved from a restricted number of B-cell clones through somatic mutation with high replacement-to-silent mutation ratios. Although V(H)3-30-encoded heavy chains were found with light chains encoded by several different Ig genes, molecular repairing experiments showed exquisite restriction on the specific heavy- and light-chain pairings that permitted platelet reactivity. Together, these data suggest that the development of platelet-reactive antibodies associated with ITP is driven by an encounter with diverse platelet antigens through the clonal expansion of B cells using genetically restricted and highly specific combinations of heavy- and light-chain gene products. The extraordinarily high usage of the V(H)3-30 heavy-chain gene in these patients has implications for the pathogenesis, diagnosis, and management of chronic ITP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149222

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  The analysis and quantification of a clonal B cell response in a hyperimmunized anti-D donor.

Authors:  S E Dohmen; O J H M Verhagen; S M de Groot; L M Stott; R C Aalberse; S J Urbaniak; C E van der Schoot
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

Review 3.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

4.  Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy.

Authors:  John R Stanley; Ken Ishii; Don L Siegel; Aimee S Payne
Journal:  Vet Dermatol       Date:  2009-10       Impact factor: 1.589

Review 5.  B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

Review 6.  B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.

Authors:  Angela Lee Foreman; Judy Van de Water; Marie-Lise Gougeon; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2007-01-12       Impact factor: 9.754

7.  The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies.

Authors:  Zhao-Hua Zhou; Yahong Zhang; Ya-Fang Hu; Larry M Wahl; John O Cisar; Abner Louis Notkins
Journal:  Cell Host Microbe       Date:  2007-03-15       Impact factor: 21.023

Review 8.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

Review 9.  Advances in immunopathogenesis of adult immune thrombocytopenia.

Authors:  Xinguang Liu; Yu Hou; Jun Peng
Journal:  Front Med       Date:  2013-11-21       Impact factor: 4.592

Review 10.  Translational applications of antibody phage display.

Authors:  Don L Siegel
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.